Prevention in PD: a six-month lifestyle program for PD and RBD
Official title: PREVENTION-IN-PD - Development of a Multidomain Lifestyle Intervention Study for Prodromal and Clinical Parkinson's Disease
Run by University Hospital Schleswig-Holstein · NCT07297407 · Data updated 2026-11-12
This study tests whether a six-month, structured lifestyle program combining exercise, Mediterranean diet, sleep guidance, and cognitive training helps people with Parkinson’s disease or REM sleep behavior disorder stick to healthier habits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 85 Years |
| Sex | All |
| Enrollment | 99 (estimated) |
| Sponsor | University Hospital Schleswig-Holstein Academic / other |
| Locations | 1 site (Kiel) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | September 2027 |
| Study ends | January 2028 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07297407 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 30 to 85 with either early-to-moderate PD (Hoehn and Yahr 1–2.5) or polysomnographically confirmed iRBD, who are willing to participate in group and online sessions.
✕Probably not a fit
Individuals with dementia, significant depression, major medical CNS diseases, or those planning medication changes in the next six months may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This feasibility trial investigates if a multimodal lifestyle program can support adherence to lifestyle changes in people with Parkinson’s disease (PD) and REM sleep behavior disorder (RBD) over six months. Participants engage in structured physical training, diet counseling, sleep optimization, and cognitive training, with psychoeducation and personalization to boost motivation. The study also looks for early signals of impact on symptoms, quality of life, and overall health. It is conducted in Germany with multiple collaborating centers and is powered to assess feasibility and potential benefits rather than definitive clinical outcomes.
Why it matters
Potential benefit: If successful, participants may experience better adherence to healthy lifestyle habits and potential improvements in quality of life and early symptom measures.
How similar studies have gone: Previous work suggests lifestyle interventions can influence health behaviors, but this exact six-month multimodal program in PD/RBD populations is being tested for feasibility and adherence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All participants: ability to perform informed consent; age 30-85 * RBD group: polysomnographic proven diagnosis of isolated REM sleep behavior disorder (iRBD) * PD group: early to moderate disease (Hoehn \& Yahr stage 1-2.5), diagnosis according to the Movement Disorder Society diagnostic criteria for clinical Parkinson's Disease * Agreement to participate in group sessions and online meetings Exclusion Criteria: * dementia (Mini Mental Score, MMSE \< 19 points) (MMSE is specifically chosen here to avoid too frequent repetitions of the MoCA, which is used as an outcome parameter for the interventional trial) * physical inability to perform exercise training or other trainings as judged by a physician * manifest (severe) depression (Beck Depression Inventory, BDI-II \> 29 points) * participation in other interventional trials * other significant diseases of the central nervous system * Planned change in medication within the following 6 months
Where it's running
-
University Hospital of Schleswig Holstein Campus Kiel
Kiel, Germany Recruiting
Study contacts
- Study coordinator: Eva Schaeffer
- Email: info.prevention.kiel@uksh.de
- Phone: 0049 043150023989
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PET-MRI to study the reward system in Parkinson's disease with RBD
This study uses PET‑MRI to see how dopamine-related reward pathways behave in people with Parkinson’s who also have REM sleep behavior disorder.
-
Safety and tolerability of EC5026 for people with Parkinson's Disease
This trial tests whether taking the oral drug EC5026 for 28 days is safe in adults with Parkinson's Disease, reaches the spinal fluid, and shows early signs of symptom benefit compared with placebo.
-
Personalized brain stimulation and walking exercises for freezing of gait in Parkinson's disease
This study is testing if a mix of brain stimulation and walking exercises can help people with Parkinson's disease who struggle with freezing while walking.
-
Exploring how people with Parkinson's disease perceive and cross obstacles while walking
This study looks at how people with Parkinson's disease see and handle obstacles while walking to help find better ways to keep them safe and reduce falls.
-
How attention and eye movements affect emotion perception in Parkinson's disease
This project will test whether deep brain stimulation changes attention, eye movements, and how people with Parkinson's disease, essential tremor, or dystonia perceive facial expressions.
-
Comparing two methods of deep brain stimulation for Parkinson's disease
This study is testing which method of deep brain stimulation—constant current or constant voltage—works better and makes people with Parkinson's disease happier after their surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.